A study Candida no-albicans species and its relationship to recurrent vulvovaginal candidiasis;Estudio de especies de Candida no albicans y su relación con candidiasis vulvovaginal recurrente

Ginecologia y Obstetricia de Mexico

Volumn 70, Issue SEPT., 2002, Pages 431-436

  Garcf, Rafael Buitr ^a,b   Romero Cabello, R A ^a,b   Talonia, Fernando Cruz ^a   Bonifaz, Alexandro ^a   Marquez, Favio Zarama ^a  

^a HÔPITAL DU BOCAGE   (France)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Recurrent genital candidiasis

Indexed keywords

ARTICLE; BACTERIUM IDENTIFICATION; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA TROPICALIS; GENITAL CANDIDIASIS; HUMAN; INCIDENCE; RECURRENT INFECTION; ADOLESCENT; ADULT; CANDIDA; COMPARATIVE STUDY; FEMALE; ISOLATION AND PURIFICATION; MICROBIOLOGY; RECURRENT DISEASE; VAGINA CANDIDIASIS;

ADOLESCENT; ADULT; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CANDIDIASIS, VULVOVAGINAL; FEMALE; HUMANS; RECURRENCE;

EID: 0036718843     PISSN: 03009041     EISSN: 03009041     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Abbas J, Bodey G P, Hanna HA et al. Candida krusei fungemia: an escalating serious infection in immunocompromised hosts. Arch Intern Med 2000; 160: 2659-64.
2. Abi-Said DE, Anaissie O, Uzun I et al. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997; 24: 1122-8.
3. Anaissie E, Hachem R, Tin-UCK et al. Experimental hematogenous candidiasis caused by Candida krusei and Candida albicans: species differences in pathogenicity. Infect Immun 1993; 61: 1268-71.
4. Anaissie E J, Karyotakis N C, Hachmen R et al. Correlation between in vitro and in vivo activity of antifungal agents against Candida species. J Infect Dis 1994; 170: 384-9.
5. Baily G G, Moore C B, Essayag S M et al. Candida inconspicua, a fluconazole-resistant pathogen in patients infected with human immunodeficiency virus. Clin Infect Dis 1997; 25: 161-3.
6. Banedee S N, Emori T G, Culver D H et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am J Med 1991; 91: 86S-89S.
7. Barchiesi F, Calabrese D, Sanglard D et al. Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750. Antimicrob Agents Chemother 2000; 44: 1578-84.
8. Barchiesi F, Falconi Di Francesco L, Arzeni D et al. Electrophoretic karyotyping and triazole susceptibility of Candida glabrata clinical isolates. Eur J Clin Microbiol Infect Dis 1999; 18: 184-7.
9. Fridkin SK, Jarvis WR. Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 1996; 9: 499-511.
10. Hazen KC. New and emerging yeast pathogens. Clin Microbiol Rev 1995; 8: 462-478.
11. Pfaller M, Wenzel R. Impact of the changing epidemiology of fungal infections in the 1990s. Eur J Clin Microbiol Infect Dis 1992; 11: 287-91.
12. Pfalier MA, Jones RN, Doern GV, et al. International surveillance of blood stream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. Diagn Microbiol Infect Dis 1999; 35: 19-25.
13. Odds FC. Candida and Candidosis: a Review and Bibliography, 2nd ed. Bailli Tindall. 1988. London, United Kingdom.
14. Pfalier MA. Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin Infect Dis 1996; 22: S89-S94.
15. Sullivan DJ, Westemeng TJ, Haynes K A et al. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 1995; 141: 1507-21.
16. Barns SM, Lane DJ, Sogin ML et al. Evolutionary relationships among pathogenic Candida species and relativas. J Bacteriol 1991; 173: 2250-5.
17. Wickes BL, Golin JE, Kwon-Chung KJ. Chromosomal rearrangement in Candida stellatoidea results in a positive effect on phenotype. Infect Immun 1991; 59: 1762-71.
18. Sullivan DJ, Henman MC, Moran GP et al. Molecular genetic approaches to identification, epidemiology and taxonomy of non albicans Candida species. J Med Microbiol 1996; 44: 399-408.
19. Samaranayake YH, Samaranayake LP. Candida krusei: biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen. J Med Microbiol 1994; 41: 295-310.
20. De Bernardis F, Mondello F, San MillR et al. Biotyping and virulence properties of skin isolates of Candida parapsilosis. J Clin Microbiol 1999; 37: 3481-6.
21. Berrouane YF, Hollis RJ, Pfaller MA. Strain variation among and antifungal susceptibilities of isolates of Candida krusei. J Clin Microbiol 1996; 34: 1856-8.
22. Groli AH, De Lucca AJ, Walsh TJ. Emerging targets for the development of novel antifungal therapeutics. Trends Microbiol 1998; 6: 117-24.
23. Kiepser ME, Wolfe EJ, Jones RN et al. Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans. Antimicrob Agents Chemother 1997; 41: 1392-5.
24. Price MF, La Rocco MT, Gentry LO. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob Agents Chemother 1994; 38: 1422-4.
25. Rex JH, Pfaller MA, Galgiani JN et al. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clin Infect Dis 1997; 24: 235-47.
26. Rex JH, Walsh TJ, Sobel JD et al. Practice guidelines for the treatment of candidiasis. Clin Infect Dis 2000; 30: 662-78.
27. Fidel PL, Vazquez JA, Sobel JD. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 1999; 12: 80-96.
28. Warnock DW, Burke J, Cope NJ et al. Fluconazole resistance in Candida glabrata. Lancet 1988; 2: 1310.
29. Sobej JD. Vulvovaginitis due to Candida glabrata An emerging problem. Mycoses 1998; 41: 18-22.
30. Pfaller MA, Messer SA, Houston A et al. National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species. Diagn Microbiol Infect Dis 1998; 31: 289-96.